FDA warns Curaleaf about inflated claims in CBD product marketing [pTi1kLG_DdO]
FDA warns Curaleaf about inflated claims in CBD product marketing [pTi1kLG_DdO]
| 1h 28m 28s | Video has closed captioning.
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain. #amazon power cbd gummies #guava cbd gummies #cbd oil gummies edibles #cbd gummies cloud 9
Aired: January 19, 2025
Buy Now:
Problems Playing Video? | Closed Captioning